moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here to view […]
[GlobeNewswire] – First Scientific Meeting to Present Preclinical Proof-of-Concept Data for Next-Generation Pompe ERT and Proprietary Enzyme Targeting Technology moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here to view […]
[GlobeNewswire] – CRANBURY, N.J. — Amicus Therapeutics , a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that William D. Chip Baird, Chief … moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here to view […]
[at noodls] – CHART Programs Advancing in Lysosomal Storage Diseases 12-Month Results from Ongoing Phase 3 Fabry Disease Monotherapy Study Expected 3Q13 CRANBURY, N.J., March 12, 2013 (GLOBE NEWSWIRE) — Amicus Therapeutics … moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here to view […]
[at noodls] – CRANBURY, N.J., March 7, 2013 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call and live audio webcast on Tuesday, March 12, 2013 at 5:00 p.m. ET to discuss financial … moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here […]
[at noodls] – New Platform Designation Reflects Development Strategy and Emphasis on Next-Generation Enzyme Replacement Therapies for Lysosomal Storage Diseases CRANBURY, N.J., March 4, 2013 (GLOBE NEWSWIRE) — Amicus … moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here to view […]
[at noodls] – Conference Call Today at 11:30am ET CRANBURY, N.J. and ORLANDO, Fla., Feb. 15, 2013 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD), today announced additional 6-month (Stage 1) results from the … moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here to view […]
[at noodls] – Phase 2 AT2220-ERT Co-Administration and Preclinical AT2220-ERT Co-Formulation Studies Presented at LDN WORLD Symposium Next-Generation ERT Advancing in Preclinical Studies Conference Call on February … moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here to view […]
[at noodls] – Conference Call on Friday, February 15 at 11:30am ET CRANBURY, N.J., Feb. 7, 2013 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD) today announced that 2 oral presentations and 5 posters related to … moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here to […]
[at noodls] – CRANBURY, N.J., Feb. 4, 2013 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will participate in two upcoming conferences … moreView todays social media effects on FOLDView the latest stocks trending across Twitter. Click to view dashboardSee who Amicus is hiring next, click here to view […]
